Humacyte (HUMA) Interest Coverage Ratio (2020 - 2026)
Humacyte (HUMA) reported Interest Coverage Ratio of 12.74 for Q1 2026, down 64.76% year-over-year from 36.15 in Q1 2025, and down 27.8% quarter-over-quarter from 9.97 in Q4 2025.
Humacyte (HUMA) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Humacyte (HUMA) has 7 years of Interest Coverage Ratio data on file, last reported at 12.74 in Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 12.74, down 64.76% year-over-year; the trailing twelve-month figure through Mar 2026 was 10.82 (down 1.99% YoY), and the FY2025 annual result was 9.61, up 22.05% from the prior year.
- Interest Coverage Ratio retreated to 12.74 in Q1 2026 per HUMA's latest filing, from 9.97 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 7.73 in Q1 2025 and troughed at 16.83 in Q3 2023.
- A 5-year average of 12.76 and a median of 12.7 in 2022 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2026: Interest Coverage Ratio jumped 59.03% in 2022, then slumped 64.76% in 2026.
- A 5-year view of Interest Coverage Ratio shows it stood at 12.7 in 2022, then dropped by 19.39% to 15.16 in 2023, then gained by 26.1% to 11.2 in 2024, then rose by 11.02% to 9.97 in 2025, then retreated by 27.8% to 12.74 in 2026.
- Business Quant data shows HUMA's Interest Coverage Ratio at 12.74 in Q1 2026, 9.97 in Q4 2025, and 9.34 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -258.33 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 11.79 |
| 10 | Humacyte | 267.09 Mn | 218.55 Mn | -1.54 Mn | -12.74 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.74 |
| Dec 31, 2025 | -9.97 |
| Sep 30, 2025 | -9.34 |
| Jun 30, 2025 | -11.68 |
| Mar 31, 2025 | -7.73 |
| Dec 31, 2024 | -11.20 |
| Sep 30, 2024 | -12.40 |
| Jun 30, 2024 | -11.73 |
| Mar 31, 2024 | -14.64 |
| Dec 31, 2023 | -15.16 |
| Sep 30, 2023 | -16.83 |
| Jun 30, 2023 | -15.63 |
| Mar 31, 2023 | -13.25 |
| Dec 31, 2022 | -12.70 |
| Sep 30, 2022 | -14.32 |
| Jun 30, 2022 | -12.45 |
| Mar 31, 2022 | -15.20 |
| Dec 31, 2021 | -15.49 |
| Sep 30, 2021 | -17.06 |
| Jun 30, 2021 | -15.86 |